Medikaloka Hermina Tbk PT
IDX:HEAL

Watchlist Manager
Medikaloka Hermina Tbk PT Logo
Medikaloka Hermina Tbk PT
IDX:HEAL
Watchlist
Price: 1 395 IDR 2.57% Market Closed
Market Cap: 20.6T IDR
Have any thoughts about
Medikaloka Hermina Tbk PT?
Write Note

Medikaloka Hermina Tbk PT
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medikaloka Hermina Tbk PT
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Medikaloka Hermina Tbk PT
IDX:HEAL
Operating Income
Rp1T
CAGR 3-Years
-18%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Siloam International Hospitals Tbk PT
IDX:SILO
Operating Income
Rp1.7T
CAGR 3-Years
17%
CAGR 5-Years
42%
CAGR 10-Years
28%
Metro Healthcare Indonesia Tbk PT
IDX:CARE
Operating Income
-Rp36.1B
CAGR 3-Years
-33%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
S
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
Operating Income
Rp177.5B
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
Operating Income
Rp1.4T
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
10%
F
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
Operating Income
Rp204.4B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medikaloka Hermina Tbk PT
Glance View

Market Cap
20.8T IDR
Industry
Health Care

PT Medikaloka Hermina engages in healthcare services. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 15,086 full-time employees. The company went IPO on 2018-05-16. The firm is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology and surgery. The Company’s subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).

HEAL Intrinsic Value
1 284.18 IDR
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Medikaloka Hermina Tbk PT's Operating Income?
Operating Income
1T IDR

Based on the financial report for Sep 30, 2024, Medikaloka Hermina Tbk PT's Operating Income amounts to 1T IDR.

What is Medikaloka Hermina Tbk PT's Operating Income growth rate?
Operating Income CAGR 5Y
14%

Over the last year, the Operating Income growth was 41%. The average annual Operating Income growth rates for Medikaloka Hermina Tbk PT have been -18% over the past three years , 14% over the past five years .

Back to Top